Redefining Cure in Multiple Myeloma: Are We Chasing a Moving Target?

Reframing cure as a spectrum rather than an absolute state offers a more realistic framework for MM management. By leveraging precision medicine and integrating QoL considerations, clinicians and researchers can foster durable remissions and improve patient outcomes. This perspective advocates for a paradigm shift, urging the MM community to embrace biological complexity and redefine success in this evolving therapeutic landscape.